Dosimetry is integral to informed implementation of radiopharmaceutical therapies, enabling personalized treatment planning ...

Large language models (LLMs) are poised to have a disruptive impact on health care. Numerous studies have demonstrated ...

Ken Herrmann, MD, MBA, from the Universitätsklinikum Essen (Germany), and Johannes Czernin, MD, from the David Geffen School ...

Perspective on Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery ...

Data were collected in 2 separate protocols, 1 to evaluate the dose-range flexibility and 1 to assess test–retest variability. In both protocols, subjects were recruited from the community by the ...

Optical techniques, such as bioluminescence and fluorescence, are emerging as powerful new modalities for molecular imaging in disease and therapy. Combining innovative molecular biology and chemistry ...

A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18 F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism ...

Radiologic imaging is claimed to carry an iatrogenic risk of cancer, based on an uninformed commitment to the 70-y-old linear no-threshold hypothesis (LNTH). Credible evidence of imaging-related ...

Journal of Nuclear Medicine January 2025, jnumed.124.268520; DOI: https://doi.org/10.2967/jnumed.124.268520 ...

The approval of new imaging agents has slowed, much as for therapeutic drugs. Schering and Amersham, for instance, each spent about $150 million a year for the period 1999–2004 on imaging agent ...

There is currently a need for imaging methods capable of detecting cell death in tissues and the early onset of tumor cell death resulting from therapy. However, to date, no probe has been approved ...